Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CARBOGEN AMCIS, a provider of services to the pharmaceutical and biopharmaceutical industry at all stages of drug development, plans to restructure its operations in Bubendorf (BL), Aarau (AG) and Hunzenschwil (Neuland, AG).
Subscribe to our email newsletter
CARBOGEN is owned by Dishman Pharmaceuticals and Chemicals of Ahmadabad, India.
CARBOGEN, which has approximately 350 employees in Switzerland, is taking this step on the grounds of the poor profitability brought about by the strong Swiss franc and the delayed effects of the financial crisis.
The planned restructuring of the Switzerland-based pharmaceutical services company will allow the Aarau site to focus more strongly on development and the Hunzenschwil (Neuland) site on the pilot production of early phase projects.
Large-volume production and the manufacturing of highly active agents will continue at the Bubendorf site.
The concentration of the areas of responsibility will mean that approximately 60 persons will need to be made redundant.
CARBOGEN is strengthening man power in the Hunzenschwil (Neuland) site to innovatively meet customer demand further on.
The company said as far as possible, employees will be offered equivalent positions in Switzerland.
Dishman Group managing director and CARBOGEN owner Jay Vyas said restructuring allows CARBOGEN to be prepared for the future as a sustainably successful organization and the restructured company will have potential for growth and the ability to adapt itself to a changing market situation.